Read More Healthcare Industry News Medtronic (NYSE: MDT) launches Embrace Gynecology study — will Hugo RAS redefine robotic hysterectomies in the U.S.? Medtronic’s Embrace Gynecology trial tests Hugo RAS in hysterectomies—can it challenge da Vinci’s dominance and reshape women’s robotic surgery? byPallavi MadhirajuOctober 11, 2025